Stay updated on Safety of DCC-2618 in Advanced Malignancies Clinical Trial

Sign up to get notified when there's something new on the Safety of DCC-2618 in Advanced Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of DCC-2618 in Advanced Malignancies Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page’s footer revision/version number has been updated from v3.5.2 to v3.5.3, indicating a site software release rather than a change to the ClinicalTrials.gov study information.
    Difference
    0.1%
    Check dated 2026-04-24T17:15:24.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:59:45.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Layout and UI updates are visible. Core study details and eligibility criteria appear unchanged.
    Difference
    0.1%
    Check dated 2026-04-10T09:00:14.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added Mastocytosis, Systemic mast cell disease, and Gastrointestinal stromal tumor to the study's conditions list.
    Difference
    0.1%
    Check dated 2026-04-03T05:50:37.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T23:48:17.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T21:29:59.000Z thumbnail image

Stay in the know with updates to Safety of DCC-2618 in Advanced Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of DCC-2618 in Advanced Malignancies Clinical Trial page.